Companies: 10,795·Total market cap: $144.5T
Clinuvel Pharmaceuticals Limited

Clinuvel Pharmaceuticals Limited

CLVLYOTCHealthcare● Active
$6.73
+$0.13(+2.01%)
Market Cap$339153780
P/E Ratio—
52W High$9
52W Low$5.98
Overview
股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Clinuvel Pharmaceuticals Limited（CLVLY）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CLVLY · 截至 Jun 9, 2026

关键指标

EPS (TTM)$1.42clvly eps ttm · clvly earnings per shareEarnings history
PE Ratio (TTM)4.7×clvly pe ratio ttm · clvly price to earningsPE Ratio deep dive
Revenue (TTM)$186.6Mclvly revenue ttm · clvly annual revenueFull revenue history
Dividend Yield0.46%does clvly pay dividends · clvly dividend yieldDividend history
Shares Outstanding50.1Mclvly shares outstanding · clvly floatShares outstanding history
Next EarningsSep 1, 2026Est.clvly earnings date · clvly next earningsEarnings history

探索 Clinuvel Pharmaceuticals Limited 数据

clvly stock data · financials
市值$339.2Mclvly market cap · clvly valuation
分析师预测—
股息0.46%does clinuvel pharmaceuticals limited pay dividends · clvly dividend yield
营收$95.0M+7.76%clinuvel pharmaceuticals limited annual revenue · clvly revenue
盈利EPS $0.72+0.00%clvly earnings · clvly eps
市盈率4.7×clvly pe ratio · clvly price to earnings

财务快照

完整财报
FY 2025Revenue$95.0M▲ +7.76% YoY
202320242025
clinuvel pharmaceuticals limited revenue · clvly revenue 2025
FY 2025Net Income$36.2M▲ +1.50% YoY
202320242025
clinuvel pharmaceuticals limited net income · clvly profit 2025
FY 2025EPS$0.72▲ +0.00% YoY
202320242025
clvly eps · clinuvel pharmaceuticals limited earnings per share 2025
TTM:Revenue: $186.6MNet Income: $71.1MEPS: $1.42View income statement →

股票表现

完整历史
1D+2.01%
1W+2.71%
1M-1.35%
3M-8.96%
YTD-20.66%
1Y+0.41%
5Y-69.32%

关于 Clinuvel Pharmaceuticals Limited

CEOPhilippe Jacques Wolgen
IPO DateJan 30, 2008
Employees100
CountryAU
Websiteclinuvel.com

Clinuvel Pharmaceuticals Limited is a biopharmaceutical firm dedicated to creating and marketing therapies for individuals worldwide grappling with genetic, metabolic, and severe medical conditions, o…

BiotechnologyHealthcareOTCADRAU

what is clinuvel pharmaceuticals limited · clvly stock overview · clinuvel pharmaceuticals limited company profile · who is clinuvel pharmaceuticals limited ceo · clvly OTC · clinuvel pharmaceuticals limited headquarters · clinuvel pharmaceuticals limited business segments

关于股票概览与关键数据

Clinuvel Pharmaceuticals Limited（CLVLY）是 Biotechnology 行业的 Healthcare 类公司，于 Jan 30, 2008 在 OTC 上市。截至最近交易日，CLVLY 股价为 $6.73，市值约为 $339.2M。过去12个月累计回报 +0.41%，年初至今回报 -20.66%。

2025 财年 Clinuvel Pharmaceuticals Limited 营收 $95.0M。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Clinuvel Pharmaceuticals Limited（CLVLY）股价为 $6.73，在 OTC 上市，52周区间为 $5.98 – $9.00。

CLVLY 最新股价CLVLY quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议